- Home
- NXTC vs WETH Comparison
NXTC vs WETH Comparison
Compare NXTC & WETH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXTC
- WETH
- Stock Information
- Founded
- NXTC 2015
- WETH 1992
- Country
- NXTC United States
- WETH China
- Employees
- NXTC N/A
- WETH N/A
- Industry
- NXTC Biotechnology: Pharmaceutical Preparations
- WETH
- Sector
- NXTC Health Care
- WETH
- Exchange
- NXTC Nasdaq
- WETH Nasdaq
- Market Cap
- NXTC 24.6M
- WETH 26.1M
- IPO Year
- NXTC 2019
- WETH N/A
- Fundamental
- Price
- NXTC $8.71
- WETH $2.48
- Analyst Decision
- NXTC Strong Buy
- WETH
- Analyst Count
- NXTC 3
- WETH 0
- Target Price
- NXTC $23.00
- WETH N/A
- AVG Volume (30 Days)
- NXTC 85.8K
- WETH 454.8K
- Earning Date
- NXTC 11-05-2025
- WETH 11-14-2025
- Dividend Yield
- NXTC N/A
- WETH N/A
- EPS Growth
- NXTC N/A
- WETH 63.71
- EPS
- NXTC N/A
- WETH 0.63
- Revenue
- NXTC N/A
- WETH $42,877,572.00
- Revenue This Year
- NXTC N/A
- WETH N/A
- Revenue Next Year
- NXTC N/A
- WETH N/A
- P/E Ratio
- NXTC N/A
- WETH $3.91
- Revenue Growth
- NXTC N/A
- WETH 5.58
- 52 Week Low
- NXTC $2.69
- WETH $0.76
- 52 Week High
- NXTC $19.20
- WETH $3.68
- Technical
- Relative Strength Index (RSI)
- NXTC 46.50
- WETH 58.60
- Support Level
- NXTC $8.51
- WETH $2.26
- Resistance Level
- NXTC $10.56
- WETH $2.75
- Average True Range (ATR)
- NXTC 1.23
- WETH 0.49
- MACD
- NXTC -0.36
- WETH -0.02
- Stochastic Oscillator
- NXTC 1.93
- WETH 46.80
About NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.
About WETH Wetouch Technology Inc.
Wetouch Technology Inc is a touch panel supplier focused on R&D, production, and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for the automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots, and charging stations. The company sells touchscreen products both domestically in China and internationally. The company generates the majority of its revenue from the PRC, followed by the Republic of China and Korea.